CLINICAL ROLE -
New Data Show Early Initiation of Ocrelizumab Improves MS Outcomes
New 5-year data from phase 3 studies show that patients treated earlier with ocrelizumab (Ocrevus) had better outcomes on multiple measures of multiple sclerosis disease activity.
Read More
VA Data Could Prove Key in Assessing Real-World Efficacy of Hepatitis C Drugs
The national Veterans Health Administration Corporate Data Warehouse could be key in revealing accurate data on the use of direct-acting antivirals in the treatment of chronic hepatitis C virus.
Viral Video a Hit For Pharmacy Students and Dog
Ashlynn Dacus, a student at Harding University College of Pharmacy in Arkansas, was attempting to do a 'What the Fluff' challenge with her Saint Bernard, Maggie.
President Trump Signs Legislation Prohibiting Pharmacy Gag Clauses
Insurers and pharmacy benefit managers can no longer restrict pharmacies from providing drug price information to customers.
DOJ Approval Moves Forward Merger of CVS and Aetna
The Department of Justice (DOJ) today granted conditional approval to the $69 billion merger between CVS Health Corporation and Aetna Inc, as long as Aetna sells its Medicare Part D prescription drug plan business.
DOJ Clears CVS, Aetna to Move Forward with Merger
The Department of Justice approved the $69 billion CVS-Aetna merger under conditions designed to preserve competition in the marketplace.
Combo HIV Therapy Targets Latent Reservoir, Delays Viral Rebound
A new combination treatment that targets the latent reservoir of HIV may be a potential effective therapeutic strategy.
Arthritis Commonly Reported in Older Adults with Depression
A new study has found that arthritis is commonly reported in older adults with varying degrees of depression, highlighting the importance of screening and treating arthritis-related pain in these patients.
Arthritis Prevalent with Depressive Symptoms in Older Adults
Trending News Today: Insurers Provide Limited Coverage of Non-Drug Alternatives to Opioids
Top news of the day from across the health care landscape.
Trending News Today: FDA Says AcelRx Opioid No Better Than Current Therapies
Pharmacist Collaboration with Physicians Enhances Chronic Care Management
Partnering with a physician to deliver chronic care can be an important way for pharmacists to not only better service patents, but also derive additional revenue.
New Mechanism Offers Insight into Breast Cancer Treatment Resistance
Study highlights mechanism of endocrine resistance in estrogen receptor-positive breast cancers and potential therapeutic targets.
Hepatitis C Combo Effective in Patients Undergoing Treatment for Opioid Addiction
Glecaprevir/pibrentasvir found to be effective in clinical trials treating patients with hepatitis C virus also being treated for opioid substitution therapy.
Experts: Patient Support Key to Management of Hyperglycemia in Type 2 Diabetes
Ongoing access to diabetes self-management education and support, and promoting good medication adherence are among the keys to managing high blood glucose in patients with type 2 diabetes.
Generic Specialty Medications: The Paradigm Shift
Specialty medications are still mostly branded products, but patients remain hesitant to accept less expensive generic alternatives when the option is available.
National Mental Illness Awareness Week Addresses Stigmas
Stigma surrounding mental illnesses can prevent people from seeking treatment.
Arthritis Prevalent in Older Adults with Depressive Symptoms
The study points to the importance of screening for and treating arthritis-related pain in older adults with varying degrees of depression.
Trending News Today: FDA Officials Raise Concern Over Opioid Injection Abuse Potential
Trending News Today: Psoriasis Drug Effectively Treats Chronic Bowel Disease in Trial
Understanding Generational Needs Can Help Pharmacists Interact With Patients
Millennials, Generation X, and Baby Boomers all have different health care needs.
NDA Filed for Secondary Progressive Multiple Sclerosis Treatment
Siponimod is an oral, once-daily medication for the treatment of multiple sclerosis in adults.
Path to Approval First Truly Generic EpiPen
What's in a name? That which we call epinephrine by any other name would still be epinephrine.
FDA OKs Treatment for Polyneuropathy in Hereditary Transthyretin-Mediated Amyloidosis
Inotersen (Tegsedi) once-weekly subcutaneous injection is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis.
Study Reports Rates of Type 1, Type 2 Diabetes in US Adults
Survey data reveal rates of diabetes prevalence by subtype among adults.
Trending News Today: Blood Sugar Control in Type 1 Diabetes Linked to Reduced Dementia Risk
Trending News Today: FDA Approves Expanded Use of HPV Vaccine
NCPA Officials Praise Bipartisan Opioid Relief Package
Officials with the National Community Pharmacists Association called the opioid relief package that is awaiting President Trump's signature "vital."
Monday Pharmaceutical Mystery: October 8
Can you solve the pharmaceutical mystery? Each week, a new case study is presented.
HPV Vaccine Use Expanded to Include Individuals Up to Age 45 Years
Officials with the FDA have approved a supplemental application for Merck's Gardasil 9 that expands the approved use of the HPV vaccine to include women and men aged 27 to 45 years